|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.22 USD | +5.49% |
|
-26.59% | +3.19% |
| 07-31 | Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial | MT |
| 07-31 | Wedbush Adjusts Monte Rosa Therapeutics Price Target to $27 From $37, Maintains Outperform Rating | MT |
Transcripts
Search
| 15/01/25 | Monte Rosa Therapeutics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 05:15 PM | |
| 17/10/23 | Monte Rosa Therapeutics, Inc. - Special Call |
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions
